Market Analysis and Insights:
The global Artificial Intelligence in Drug Discovery market is projected to grow from US$ 1,786.76 million in 2023 to US$ 8,890.05 million by 2029, at a Compound Annual Growth Rate (CAGR) of 30.66% during the forecast period.
The global key companies of Artificial Intelligence in Drug Discovery include: IBM, Google (Alphabet), Atomwise, Schrodinger and Microsoft, etc. In 2022, the global top five players had a share approximately 18.74% in terms of revenue.
Report Includes
This report presents an overview of global market for Artificial Intelligence in Drug Discovery market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Artificial Intelligence in Drug Discovery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Artificial Intelligence in Drug Discovery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Artificial Intelligence in Drug Discovery revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Artificial Intelligence in Drug Discovery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Artificial Intelligence in Drug Discovery revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including IBM Corporation, Microsoft Corporation, Google, NVIDIA Corporation, BPGbio, Inc, Atomwise Inc, Cloud Pharmaceuticals, Insilico Medicine, and Aitia, etc.
By Company
- IBM
- Exscientia
- Google (Alphabet)
- Microsoft
- Atomwise
- Schrodinger
- Aitia
- Insilico Medicine
- NVIDIA
- XtalPi
- BPGbio
- Owkin
- CytoReason
- Deep Genomics
- Cloud Pharmaceuticals
- BenevolentAI
- Cyclica
- Verge Genomics
- Valo Health
- Envisagenics
- Euretos
- BioAge Labs
- Iktos
- BioSymetrics
- Evaxion Biotech
- Aria Pharmaceuticals
Segment by Type
- Hardware
- Software
- Service
Segment by Application
- Early Drug Discovery
- Preclinical Phase
- Clinical Phase
- Regulatory Approval
By Region
- Asia-Pacific-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Others
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Chapter Outline
- Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
- Chapter 2: Revenue of Artificial Intelligence in Drug Discovery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
- Chapter 3: Detailed analysis of Artificial Intelligence in Drug Discovery companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
- Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
- Chapter 8: Asia-Pacific by Type, by Application and by region, revenue for each segment.
- Chapter 9: Latin America by Type, by Application and by region, revenue for each segment.
- Chapter 10: Middle East, Africa by Type, by Application and by country, revenue for each segment.
- Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence in Drug Discovery revenue, gross margin, and recent development, etc.
- Chapter 12: Analyst's Viewpoints/Conclusions
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Artificial Intelligence in Drug Discovery Market Size Growth Rate by Type: 2018 VS 2023 VS 2029
- 1.2.2 Hardware
- 1.2.3 Software
- 1.2.4 Service
- 1.3 Market by Application
- 1.3.1 Global Artificial Intelligence in Drug Discovery Market Share by Application: 2018 VS 2023 VS 2029
- 1.3.2 Early Drug Discovery
- 1.3.3 Preclinical Phase
- 1.3.4 Clinical Phase
- 1.3.5 Regulatory Approval
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Artificial Intelligence in Drug Discovery Market Perspective (2018-2029)
- 2.2 Global Artificial Intelligence in Drug Discovery Growth Trends by Region
- 2.2.1 Global Artificial Intelligence in Drug Discovery Market Size by Region: 2018 VS 2023 VS 2029
- 2.2.2 Artificial Intelligence in Drug Discovery Historic Market Size by Region (2018-2023)
- 2.2.3 Artificial Intelligence in Drug Discovery Forecasted Market Size by Region (2024-2029)
- 2.3 Artificial Intelligence in Drug Discovery Market Dynamics
- 2.3.1 Artificial Intelligence in Drug Discovery Industry Trends
- 2.3.2 Artificial Intelligence in Drug Discovery Market Drivers
- 2.3.3 Artificial Intelligence in Drug Discovery Market Challenges
- 2.3.4 Artificial Intelligence in Drug Discovery Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Revenue Artificial Intelligence in Drug Discovery by Players
- 3.1.1 Global Artificial Intelligence in Drug Discovery Revenue by Players (2018-2023)
- 3.1.2 Global Artificial Intelligence in Drug Discovery Revenue Market Share by Players (2018-2023)
- 3.2 Global Artificial Intelligence in Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Global Key Players of Artificial Intelligence in Drug Discovery, Ranking by Revenue, 2021 VS 2022 VS 2023
- 3.4 Global Artificial Intelligence in Drug Discovery Market Concentration Ratio
- 3.4.1 Global Artificial Intelligence in Drug Discovery Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence in Drug Discovery Revenue in 2022
- 3.5 Global Key Players of Artificial Intelligence in Drug Discovery Head office and Area Served
- 3.6 Global Key Players of Artificial Intelligence in Drug Discovery Established Date
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence in Drug Discovery Breakdown Data by Type
- 4.1 Global Artificial Intelligence in Drug Discovery Historic Market Size by Type (2018-2023)
- 4.2 Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Type (2024-2029)
5 Artificial Intelligence in Drug Discovery Breakdown Data by Application
- 5.1 Global Artificial Intelligence in Drug Discovery Historic Market Size by Application (2018-2023)
- 5.2 Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Application (2024-2029)
6 North America
- 6.1 North America Artificial Intelligence in Drug Discovery Market Size (2018-2029)
- 6.2 North America Artificial Intelligence in Drug Discovery Market Size by Type
- 6.2.1 North America Artificial Intelligence in Drug Discovery Market Size by Type (2018-2023)
- 6.2.2 North America Artificial Intelligence in Drug Discovery Market Size by Type (2024-2029)
- 6.2.3 North America Artificial Intelligence in Drug Discovery Market Share by Type (2018-2029)
- 6.3 North America Artificial Intelligence in Drug Discovery Market Size by Application
- 6.3.1 North America Artificial Intelligence in Drug Discovery Market Size by Application (2018-2023)
- 6.3.2 North America Artificial Intelligence in Drug Discovery Market Size by Application (2024-2029)
- 6.3.3 North America Artificial Intelligence in Drug Discovery Market Share by Application (2018-2029)
- 6.4 North America Artificial Intelligence in Drug Discovery Market Size by Country
- 6.4.1 North America Artificial Intelligence in Drug Discovery Market Size by Country: 2018 VS 2023 VS 2029
- 6.4.2 North America Artificial Intelligence in Drug Discovery Market Size by Country (2018-2023)
- 6.4.3 North America Artificial Intelligence in Drug Discovery Market Share by Country (2024-2029)
- 6.4.4 United States
- 6.4.5 Canada
7 Europe
- 7.1 Europe Artificial Intelligence in Drug Discovery Market Size (2018-2029)
- 7.2 Europe Artificial Intelligence in Drug Discovery Market Size by Type
- 7.2.1 Europe Artificial Intelligence in Drug Discovery Market Size by Type (2018-2023)
- 7.2.2 Europe Artificial Intelligence in Drug Discovery Market Size by Type (2024-2029)
- 7.2.3 Europe Artificial Intelligence in Drug Discovery Market Share by Type (2018-2029)
- 7.3 Europe Artificial Intelligence in Drug Discovery Market Size by Application
- 7.3.1 Europe Artificial Intelligence in Drug Discovery Market Size by Application (2018-2023)
- 7.3.2 Europe Artificial Intelligence in Drug Discovery Market Size by Application (2024-2029)
- 7.3.3 Europe Artificial Intelligence in Drug Discovery Market Share by Application (2018-2029)
- 7.4 Europe Artificial Intelligence in Drug Discovery Market Size by Country
- 7.4.1 Europe Artificial Intelligence in Drug Discovery Market Size by Country: 2018 VS 2023 VS 2029
- 7.4.2 Europe Artificial Intelligence in Drug Discovery Market Size by Country (2018-2023)
- 7.4.3 Europe Artificial Intelligence in Drug Discovery Market Size by Country (2024-2029)
- 7.4.4 Germany
- 7.4.5 France
- 7.4.6 U.K.
- 7.4.7 Italy
- 7.4.8 Russia
8 Asia-Pacific
- 8.1 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size (2018-2029)
- 8.2 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Type
- 8.2.1 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Type (2018-2023)
- 8.2.2 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Type (2024-2029)
- 8.2.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Share by Type (2018-2029)
- 8.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Application
- 8.3.1 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Application (2018-2023)
- 8.3.2 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Application (2024-2029)
- 8.3.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Share by Application (2018-2029)
- 8.4 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region
- 8.4.1 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region: 2018 VS 2023 VS 2029
- 8.4.2 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region (2018-2023)
- 8.4.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region (2024-2029)
- 8.4.4 China
- 8.4.5 Japan
- 8.4.6 South Korea
- 8.4.7 Southeast Asia
- 8.4.8 India
- 8.4.9 Australia
9 Latin America
- 9.1 Latin America Artificial Intelligence in Drug Discovery Market Size (2018-2029)
- 9.2 Latin America Artificial Intelligence in Drug Discovery Market Size by Type
- 9.2.1 Latin America Artificial Intelligence in Drug Discovery Market Size by Type (2018-2023)
- 9.2.2 Latin America Artificial Intelligence in Drug Discovery Market Size by Type (2024-2029)
- 9.2.3 Latin America Artificial Intelligence in Drug Discovery Market Share by Type (2018-2029)
- 9.3 Latin America Artificial Intelligence in Drug Discovery Market Size by Application
- 9.3.1 Latin America Artificial Intelligence in Drug Discovery Market Size by Application (2018-2023)
- 9.3.2 Latin America Artificial Intelligence in Drug Discovery Market Size by Application (2024-2029)
- 9.3.3 Latin America Artificial Intelligence in Drug Discovery Market Share by Application (2018-2029)
- 9.4 Latin America Artificial Intelligence in Drug Discovery Market Size by Country
- 9.4.1 Latin America Artificial Intelligence in Drug Discovery Market Size by Country: 2018 VS 2023 VS 2029
- 9.4.2 Latin America Artificial Intelligence in Drug Discovery Market Size by Country (2018-2023)
- 9.4.3 Latin America Artificial Intelligence in Drug Discovery Market Size by Country (2024-2029)
- 9.4.4 Mexico
- 9.4.5 Brazil
10 Middle East, Africa
- 10.1 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size (2018-2029)
- 10.2 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Type
- 10.2.1 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Type (2018-2023)
- 10.2.2 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Type (2024-2029)
- 10.2.3 Middle East, Africa Artificial Intelligence in Drug Discovery Market Share by Type (2018-2029)
- 10.3 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Application
- 10.3.1 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Application (2018-2023)
- 10.3.2 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Application (2024-2029)
- 10.3.3 Middle East, Africa Artificial Intelligence in Drug Discovery Market Share by Application (2018-2029)
- 10.4 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Country
- 10.4.1 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Country: 2018 VS 2023 VS 2029
- 10.4.2 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Country (2018-2023)
- 10.4.3 Middle East, Africa Artificial Intelligence in Drug Discovery Market Size by Country (2024-2029)
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
- 10.4.6 Egypt
- 10.4.7 South Africa
11 Key Players Profiles
- 11.1 IBM Corporation
- 11.1.1 IBM Corporation Company Details
- 11.1.2 IBM Corporation Business Overview
- 11.1.3 IBM Corporation Artificial Intelligence in Drug Discovery Introduction
- 11.1.4 IBM Corporation Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.1.5 IBM Corporation Recent Development
- 11.2 Exscientia
- 11.2.1 Exscientia Company Details
- 11.2.2 Exscientia Business Overview
- 11.2.3 Exscientia Artificial Intelligence in Drug Discovery Introduction
- 11.2.4 Exscientia Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.2.5 Exscientia Recent Development
- 11.3 Google (Alphabet)
- 11.3.1 Google (Alphabet) Company Details
- 11.3.2 Google (Alphabet) Business Overview
- 11.3.3 Google (Alphabet) Artificial Intelligence in Drug Discovery Introduction
- 11.3.4 Google (Alphabet) Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.3.5 Google (Alphabet) Recent Development
- 11.4 Microsoft Corporation
- 11.4.1 Microsoft Corporation Company Details
- 11.4.2 Microsoft Corporation Business Overview
- 11.4.3 Microsoft Corporation Artificial Intelligence in Drug Discovery Introduction
- 11.4.4 Microsoft Corporation Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.4.5 Microsoft Corporation Recent Development
- 11.5 Atomwise Inc
- 11.5.1 Atomwise Inc Company Details
- 11.5.2 Atomwise Inc Business Overview
- 11.5.3 Atomwise Inc Artificial Intelligence in Drug Discovery Introduction
- 11.5.4 Atomwise Inc Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.5.5 Atomwise Inc Recent Development
- 11.6 Schrodinger
- 11.6.1 Schrodinger Company Details
- 11.6.2 Schrodinger Business Overview
- 11.6.3 Schrodinger Artificial Intelligence in Drug Discovery Introduction
- 11.6.4 Schrodinger Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.6.5 Schrodinger Recent Development
- 11.7 Aitia
- 11.7.1 Aitia Company Details
- 11.7.2 Aitia Business Overview
- 11.7.3 Aitia Artificial Intelligence in Drug Discovery Introduction
- 11.7.4 Aitia Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.7.5 Aitia Recent Development
- 11.8 Insilico Medicine
- 11.8.1 Insilico Medicine Company Details
- 11.8.2 Insilico Medicine Business Overview
- 11.8.3 Insilico Medicine Artificial Intelligence in Drug Discovery Introduction
- 11.8.4 Insilico Medicine Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.8.5 Insilico Medicine Recent Development
- 11.9 NVIDIA Corporation
- 11.9.1 NVIDIA Corporation Company Details
- 11.9.2 NVIDIA Corporation Business Overview
- 11.9.3 NVIDIA Corporation Artificial Intelligence in Drug Discovery Introduction
- 11.9.4 NVIDIA Corporation Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.9.5 NVIDIA Corporation Recent Development
- 11.10 XtalPi
- 11.10.1 XtalPi Company Details
- 11.10.2 XtalPi Business Overview
- 11.10.3 XtalPi Artificial Intelligence in Drug Discovery Introduction
- 11.10.4 XtalPi Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.10.5 XtalPi Recent Development
- 11.11 BPGbio, Inc
- 11.11.1 BPGbio, Inc Company Details
- 11.11.2 BPGbio, Inc Business Overview
- 11.11.3 BPGbio, Inc Artificial Intelligence in Drug Discovery Introduction
- 11.11.4 BPGbio, Inc Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.11.5 BPGbio, Inc Recent Development
- 11.12 Owkin Inc
- 11.12.1 Owkin Inc Company Details
- 11.12.2 Owkin Inc Business Overview
- 11.12.3 Owkin Inc Artificial Intelligence in Drug Discovery Introduction
- 11.12.4 Owkin Inc Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.12.5 Owkin Inc Recent Development
- 11.13 CytoReason
- 11.13.1 CytoReason Company Details
- 11.13.2 CytoReason Business Overview
- 11.13.3 CytoReason Artificial Intelligence in Drug Discovery Introduction
- 11.13.4 CytoReason Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.13.5 CytoReason Recent Development
- 11.14 Deep Genomics
- 11.14.1 Deep Genomics Company Details
- 11.14.2 Deep Genomics Business Overview
- 11.14.3 Deep Genomics Artificial Intelligence in Drug Discovery Introduction
- 11.14.4 Deep Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.14.5 Deep Genomics Recent Development
- 11.15 Cloud Pharmaceuticals
- 11.15.1 Cloud Pharmaceuticals Company Details
- 11.15.2 Cloud Pharmaceuticals Business Overview
- 11.15.3 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Introduction
- 11.15.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.15.5 Cloud Pharmaceuticals Recent Development
- 11.16 BenevolentAI
- 11.16.1 BenevolentAI Company Details
- 11.16.2 BenevolentAI Business Overview
- 11.16.3 BenevolentAI Artificial Intelligence in Drug Discovery Introduction
- 11.16.4 BenevolentAI Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.16.5 BenevolentAI Recent Development
- 11.17 Cyclica
- 11.17.1 Cyclica Company Details
- 11.17.2 Cyclica Business Overview
- 11.17.3 Cyclica Artificial Intelligence in Drug Discovery Introduction
- 11.17.4 Cyclica Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.17.5 Cyclica Recent Development
- 11.18 Verge Genomics
- 11.18.1 Verge Genomics Company Details
- 11.18.2 Verge Genomics Business Overview
- 11.18.3 Verge Genomics Artificial Intelligence in Drug Discovery Introduction
- 11.18.4 Verge Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.18.5 Verge Genomics Recent Development
- 11.19 Valo Health
- 11.19.1 Valo Health Company Details
- 11.19.2 Valo Health Business Overview
- 11.19.3 Valo Health Artificial Intelligence in Drug Discovery Introduction
- 11.19.4 Valo Health Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.19.5 Valo Health Recent Development
- 11.20 Envisagenics
- 11.20.1 Envisagenics Company Details
- 11.20.2 Envisagenics Business Overview
- 11.20.3 Envisagenics Artificial Intelligence in Drug Discovery Introduction
- 11.20.4 Envisagenics Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.20.5 Envisagenics Recent Development
- 11.21 Euretos
- 11.21.1 Euretos Company Details
- 11.21.2 Euretos Business Overview
- 11.21.3 Euretos Artificial Intelligence in Drug Discovery Introduction
- 11.21.4 Euretos Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.21.5 Euretos Recent Development
- 11.22 BioAge Labs
- 11.22.1 BioAge Labs Company Details
- 11.22.2 BioAge Labs Business Overview
- 11.22.3 BioAge Labs Artificial Intelligence in Drug Discovery Introduction
- 11.22.4 BioAge Labs Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.22.5 BioAge Labs Recent Development
- 11.23 Iktos
- 11.23.1 Iktos Company Details
- 11.23.2 Iktos Business Overview
- 11.23.3 Iktos Artificial Intelligence in Drug Discovery Introduction
- 11.23.4 Iktos Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.23.5 Iktos Recent Development
- 11.24 BioSymetrics
- 11.24.1 BioSymetrics Company Details
- 11.24.2 BioSymetrics Business Overview
- 11.24.3 BioSymetrics Artificial Intelligence in Drug Discovery Introduction
- 11.24.4 BioSymetrics Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.24.5 BioSymetrics Recent Development
- 11.25 Evaxion Biotech A/S
- 11.25.1 Evaxion Biotech A/S Company Details
- 11.25.2 Evaxion Biotech A/S Business Overview
- 11.25.3 Evaxion Biotech A/S Artificial Intelligence in Drug Discovery Introduction
- 11.25.4 Evaxion Biotech A/S Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.25.5 Evaxion Biotech A/S Recent Development
- 11.26 Aria Pharmaceuticals, Inc
- 11.26.1 Aria Pharmaceuticals, Inc Company Details
- 11.26.2 Aria Pharmaceuticals, Inc Business Overview
- 11.26.3 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Introduction
- 11.26.4 Aria Pharmaceuticals, Inc Revenue in Artificial Intelligence in Drug Discovery Business (2018-2023)
- 11.26.5 Aria Pharmaceuticals, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer